Article Text

PDF
Canine health
Switching between medications for the management of epilepsy in dogs
  1. Jacques Penderis1 and
  2. Holger Volk2
  1. 1School of Veterinary Medicine, University of Glasgow, Garscube Estate, Bearsden Road, Glasgow G61 1QH
  2. 2Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire AL9 7TA

Statistics from Altmetric.com

FOLLOWING the recent release of a novel medication for the management of idiopathic epilepsy in dogs, we are now in the rather fortunate position of being able to choose between two veterinary products licensed for the initiation of therapy. Both phenobarbital and imepitoin have been shown to be effective in dogs with idiopathic epilepsy and afford us the possibility to tailor our antiepileptic therapy specifically to the individual needs of a patient. In the past, if a dog demonstrated deleterious side effects on phenobarbital therapy, then there was not the option to change to a different veterinary product licensed as a sole therapy for idiopathic epilepsy …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.